# A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis

> **NCT02545907** · PHASE1,PHASE2 · COMPLETED · sponsor: **University College, London** · enrollment: 10 (actual)

## Conditions studied

- Amyloidosis

## Interventions

- **DRUG:** Carfilzomib
- **DRUG:** Thalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02545907
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-14
- **Primary completion:** 2019-09-26
- **Final completion:** 2019-10-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545907, "A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02545907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*